Gene therapy for immune tolerance induction in hemophilia with inhibitors

Summary The development of inhibitors, i.e. neutralizing alloantibodies against factor (F) VIII or FIX, is the most significant complication of protein replacement therapy for patients with hemophilia, and is associated with both increased mortality and substantial physical, psychosocial and financi...

Ausführliche Beschreibung